Myasthenia gravis in iran, the course of the disease from cover to cover

      Background: Myasthenia Gravis (MG) is a potentially treatable disease among many neuromuscular disorders. Different demographic, clinical and laboratory characteristics may affect disease severity and treatment outcomes alone or in combination.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal


      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect